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Abstract Oncogenic transformation by v-Src is accompanied 
by marked morphological changes and cytoskeletal reorganiza-
tion. Yet, the cytoskeleton-associated proteins with which v-Src 
interacts are largely unknown. We have studied the binding of v-
Src-SH3 domain to cellular proteins utilizing a blot overlay 
procedure with a GST-v-Src-SH3 fusion protein as probe. A 
major 62-64 kDa v-Src-SH3-binding protein, present in 
detergent-insoluble cellular fractions, was identified as p21ras-
GTPase-activating protein-associated p62 (GAPA62). In non-
transformed cells, including NIH 3T3 cells, GAPA62 was 
present in both the RIPA-soluble and RIPA-insoluble fractions, 
but only the latter form was tyrosine-phosphorylated. In 
contrast, in polyoma middle T antigen-transformed 3T3 cells, 
GAPA62 was present only in the RIPA-insoluble fraction, where 
it was highly phosphorylated. It is suggested that tyrosine 
phosphorylation of GAPA62 may be an important determinant 
of its cellular localization and its possible function as a mediator 
of v-Src actions. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The tyrosine kinase activity of c-Src is increased in vivo 
during mitosis and in response to stimulation by growth fac-
tors [1]. The role of Src in cellular growth control is further 
illustrated by the cell transformation caused upon transfection 
with v-Src, the viral counterpart of c-Src [2-5]. However, de-
spite an extensive study, the mechanism(s) by which Src exerts 
its effect and transforms cells are not fully understood. The 
interaction of Src with other proteins is mediated by its Src 
homology (SH) 2 and SH3 domains. Src associates with ty-
rosine-phosphorylated proteins through its SH2 domain, en-
abling its SH3 domain to interact with downstream effectors. 
The SH3 domain is a 50-60 amino acid domain [6,7], found in 
various eukaryotic proteins [8,9]. The SH3 domain is hydro-
phobic in nature, and is comprised of a few highly conserved 
motifs. Determination of the 3-dimensional structure of a 
number of SH3 domains revealed that the SH3 domain is a 
compact ß-barrel in which many of the conserved amino acid 
residues are located closely together on its surface to form the 
binding site for the ligand [8,10-12], a proline-rich sequence of 
about 10 amino acids [12-14]. 
Cellular transformation by the oncogene v-Src is accompa-
nied by marked morphological changes and cytoskeletal reor-
ganization ; indeed, Src is found in association with the Triton 
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X-100-resistant cytoskeleton [15-21]. In this study we have 
examined the binding of the v-Src-SH3 domain to cellular 
proteins by utilizing a blot overlay procedure. We show that 
p21 r a s-GTPase-activating protein-associated p62 (GAPA62) is 
one of the main targets of v-Src-SH3 and that it is enriched in 
detergent-insoluble fractions where it is phosphorylated on 
tyrosine residues. 
2. Materials and methods 
2.1. Materials 
Dithiothreitol, glutathione, glutathione cross-linked to agarose, Tri-
ton X-100, Nonidet P-40, isopropyl ß-thiogalactopyranoside (IPTG), 
phenylmethylsulfonyl fluoride (PMSF) and bovine serum albumin 
(BSA) were obtained from Sigma. Sodium deoxycholate was pur-
chased from Fluka. Sodium dodecyl sulfate was obtained from 
BDH. Horseradish peroxidase (HRP)-linked antibodies were pur-
chased from Zymed or Biomakor (Nes-Tsiona, Israel). Anti-
GAPA62 antibody was obtained from Transduction Laboratories 
and anti-phosphotyrosine (aPY) was from Santa Cruz Biotechnology. 
Enhanced chemiluminescence (ECL) reaction kit was purchased from 
Amersham. Dulbecco's modified Eagle medium (DMEM), fetal calf 
serum (FCS) and supplemented antibiotics are products of Biological 
Industries, Kibbutz Beth HaEmek, Israel. 
2.2. Cell lines and tissue culture 
HT1080 cells, derived from a metastatic lesion of human fibrosar-
coma, and NIH 3T3 cells were obtained from the American Type 
Culture Collection (ATCC). NG108-15 cells are routinely maintained 
in our laboratory. V4 cells are a kind gift from Dr. L.C. Cantley 
(Harvard Medical School, Boston, MA, USA). All cell lines were 
maintained in DMEM containing 10% FCS and supplemented with 
1000 U/ml penicillin and 100 mg/ml streptomycin. Cultures were 
maintained at 37°C. The experiments were carried out with cells which 
had been serum-deprived by an overnight incubation in DMEM con-
taining 0.1% BSA. 
2.3. Expression and purification of GST and GST-fused SH3 domains 
The pGEX-2T expression system (Pharmacia) was used to express 
SH3 domains as a fusion with glutathione 5-transferase (GST) in E. 
coli DH5a strain [22]. Overnight bacterial cultures were diluted 1:10 
in LB medium. After 2 h shaking at 37°C IPTG was added to a final 
concentration of 0.1 mM and the incubation proceeded for 4 h. The 
bacteria were harvested by centrifugation (10 min at 4225 Xg) and 
then resuspended in 1/10 volume of Ca2+/Mg2+-free PBS supple-
mented with 1 mM PMSF and 10 Jig/ml leupeptin. To extract the 
GST-SH3 fusion protein from insoluble inclusion bodies, the cells 
were lysed by sonication for 2.5 min and then centrifuged for 20 
min at 38 700Xg. In order to solubilize the included proteins, the 
pellet was resuspended in 4.5 ml of a buffer containing 8 M urea, 
25 mM Tris-HCl pH 7.5, 1 mM DTT, and 1 mM EGTA. Renatura-
tion of the proteins was accomplished by dialysis for 2 h against 4 M 
urea, 1 mM Tris-HCl pH 5.0, 1 mM DTT. Further overnight dialysis 
with one change was accomplished against 20 mM Tris-HCl pH 7.5, 
50 mM NaCl, 2 mM MgCl2, 0.2 mM DTT. 0.5 ml (1/10 of the 
volume) of 10 X MIX solution (10% Triton X-100, 1% Tween 20, 
100 mM DTT) was added, and the dialysate was cleared by an addi-
tional centrifugation for 6 min at 4300 Xg. The native GST-SH3 fu-
sion protein was purified on glutathione-agarose column (2 ml) equil-
ibrated with 1 X MIX prior to the loading of the bacterial extract. 
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Following loading and after 10 min agitation at room temperature the 
glutathione-agarose column was washed twice with 1 XMIX in Ca2+/ 
Mg2+-free PBS and twice with Ca2+/Mg2+-free PBS. Protein was 
eluted with 10 ml of 5 mM glutathione in 50 mM Tris-HCl pH 8.0. 
Fractions of 1 ml were collected and the GST or GST-fusion proteins 
were located at fractions 2 and 3 by SDS polyacrylamide gel electro-
phoresis and immunoblot analysis with anti GST antibodies. The 
GST-Fyn-SH3 domain used as a control was kindly provided by 
Dr. R. Kappeler. 
2.4. Cell fractionation and blot overlay analysis 
Serum-deprived cells were washed with Ca2+/Mg2+-free PBS and 
lysed with lysis buffer (50 mM HEPES pH 7.0, 10% glycerol, 150 
mM NaCl, 1% Triton X-100, 1.5 mM MgCl2, 1 mM EGTA, 100 
mM NaF, 10 mM sodium pyrophosphate, 10 mM NaVC>4, 1 mM 
PMSF and 10 ug/ml leupeptin). Cells were scraped, incubated with 
the lysis buffer on ice for 5 min, centrifuged (5 min) and the Triton X-
100-soluble (TS) fraction was collected. The Triton X-100-insoluble 
(TI) pellet was washed with lysis buffer and then solubilized with 
RIPA buffer (Ca2+/Mg2+-free PBS containing 1% NP40, 0.5% sodium 
deoxycholate, 0.1% SDS, 100 mM NaF, 10 mM Na-pyrophosphate, 
1-2 mM NaV04 , 1 mM PMSF and 10 |ig/ml leupeptin). Following an 
additional centrifugation the RIPA-soluble (RS) fraction was sepa-
rated from the RIPA-insoluble (RI) pellet. The RI pellet was exten-
sively washed with RIPA and solubilized in 2XSDS sample buffer 
(250 mM Tris pH 6.8, 8% SDS, 40% glycerol and 20% 2-mercapto-
ethanol). In some experiments, the RI pellet was further solubilized by 
resuspension in Ca2+/Mg2+-free PBS and a 30 s sonication, followed 
by centrifugation. In a typical experiment carried out with NIH 3T3 
cells, the TS, RS and RI fractions comprised 56.9%, 38.6% and 4.5% 
of total cellular protein, respectively. Blot overlay with GST-v-Src-
SH3 was carried out as follows. Th, TS, RS and RI fractions (3-6 
|xg protein/well) were separated on SDS-polyacrylamide gels, blotted 
onto nitrocellulose and blocked for 3 h with Ca2+/Mg2+-free PBS 
containing 0.05% Tween-20 (T-PBS) and 10% milk (homogenized, 
1% fat). Next the blots were incubated for 2 h in T-PBS, 0.5% 
BSA, containing 0.5-1.0 |ig/ml GST-fused SH3 probes. After washing 
with T-PBS the blots were incubated for 1.5 h with rabbit anti-GST 
(RaGST) serum diluted 1:15 000 in T-PBS, 0.5% BSA, 5% milk. Blots 
were washed as before and then incubated for 1.5 h with HRP-linked 
goat anti-rabbit IgG (GaR-HRP) diluted 1:15000 in T-PBS, 5% milk 
and immunoreactive bands were visualized by ECL reaction. 
2.5. Western blotting 
Western blotting was carried out on cell fractions prepared as de-
scribed above. Following protein transfer, the nitrocellulose mem-
branes were blocked for 3 h in Ca2+/Mg2+-free PBS containing 
0.05% Tween-20 (T-PBS) and 10% milk. Next the blots were incu-
bated for 2 h in T-PBS, 0.5% BSA, 5% milk, containing the first 
antibody at the indicated concentration. The blots were washed 
with T-PBS and incubated for 1.5 h with GaR-HRP or HRP-linked 
goat anti-mouse IgG (GaM-HRP) diluted 1:15 000 in T-PBS, 5% 
milk. Immunoreactive bands were visualized by ECL reaction. 
2.6. Immunoprecipitation 
Lysates were incubated with agarose-linked aPY overnight at 4°C 
and then the beads were washed three times with HNTG buffer (20 
mM HEPES pH 7.5, 150 mM NaCl, 0.1% Triton X-100, 10% glycer-
Fig. 1. GST-vSrc-SH3 binding proteins in TS, RS and RI fractions 
of various cell lines. TS, RS and RI fractions of the indicated cell 
lines were electrophoretically separated on 10% SDS-polyacrylamide 
gel and blotted on a nitrocellulose membrane. The ability of the 
blotted proteins to associate with either GST-v-Src-SH3 (A) or 
GST-Fyn-SH3 (B) was examined by blot overlay with these probes 
as described in Section 2. Association of SH3 domains was detected 
by incubation first with RaGST and then with GaR-HRP, and vis-
ualized by ECL. 
ol). The precipitated proteins were recovered with 2XSDS sample 
buffer and separated on SDS gels. 
3. Results 
Interactions of the intracellular protein tyrosine kinase c-
Src with other proteins are believed to be mediated by two 
modules within it, the SH2 and SH3 domains. Whereas the 
SH2 domain associates with phosphorylated tyrosines of sub-
strate proteins [5,23,24], the SH3 domain binds to proline-rich 
sequences of target proteins [9,12-14,25-27]. In order to study 
the interaction of v-Src-SH3 with its targets, a 154 bp frag-
ment (nucleotides 352-505) coding for 51 amino acids of the 
Schmidt-Ruppin D strain v-Src-SH3 domain [28] was ex-
pressed in fusion with GST and used to probe v-Src-SH3-
binding proteins by utilizing a blot overlay procedure. To 
compare the pattern of SH3-binding proteins in different cells, 
lysates from several cell lines were analyzed with GST-v-Src-
Fig. 2. Tyrosine phosphorylation of the 62 kDa protein. TS, RS and RI fractions of HT1080, NG108-15, NIH 3T3 and V4 cells were immuno-
blotted with aPY mAb. Immunoreactivity was detected with GaM-HRP and visualized by ECL. 
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Fig. 3. Western blot analysis of cell fractions with anti-GAPA62. Samples from TS, RS and RI fractions of NG108-15, NIH 3T3 and V4 cells 
were subjected to SDS-PAGE and then immunoblotted with anti-GAPA62. Immunoreactivity was detected with GaM-HRP and visualized by 
ECL. 
SH3 after being solubilized with lysis buffer and RIPA. Ex-
cept for minor differences, the general pattern of labeling was 
repeated in most cells examined. The most intense labeling 
appeared as a doublet in the molecular weight range of 62-
64 kDa in both the RS fraction and mainly in the RI fraction 
of NIH 3T3, NG108-15 and HT1080 cells (Fig. 1A). How-
ever, in the polyoma middle T antigen-transformed 3T3 cell 
line (V4), the 62 kDa protein appears only in the RI fraction. 
The Fyn-SH3 interacted with a limited number of bands, none 
of which corresponded to a 62 kDa protein, and its main 
target was a slightly heavier protein in the 68 kDa region 
(Fig. IB). That association was much weaker than that of 
the Src-SH3 domains and a longer exposure was required 
for its detection. The p68 band is most likely to be a protein 
designated Sam68, which was recently reported to associate 
with the Fyn-SH3 [29]. 
The above results indicate that the 62 kDa protein is a 
major v-Src-SH3-binding protein and therefore it was of in-
terest to identify and characterize it. To determine whether the 
62 kDa protein is phosphorylated, cell fractions of non-stimu-
lated NG108-15, HT1080, NIH 3T3 and V4 cells were immu-
noblotted with ocPY antibody. As expected, in non-trans-
formed cells the basal level of phosphorylation was 
relatively low, whereas in the V4 cells a high level of phos-
phorylation was evident. However, in all cell lines the 62-64 
kDa doublet is heavily phosphorylated on tyrosine (Fig. 2). 
Interestingly, only the RI form was found to be phosphoryl-
ated on tyrosine residues. A similar pattern was obtained also 
in V4 cells in which the phosphorylation level of the 62 kDa 
band was higher than that of other proteins (Fig. 2). 
It has been shown previously that in mitotically arrested 
Src-overexpressor NIH 3T3 cells there is an increase in the 
phosphorylation of Sam68 [29,30]. Sam68 is highly homolo-
gous to the Ras-GAP-associated p62 (GAPA62) and was sug-
gested to be an alternatively spliced form of the same mRNA 
[30,31]. Like the 62 kDa protein (cf. Fig. 2), Sam68 was 
shown to be phosphorylated while background tyrosine phos-
phorylation was very low. On the basis of these similarities it 
was decided to examine whether the 62 kDa band is GAPA62. 
Cell fractions were immunoblotted with anti-GAPA62 anti-
body, revealing a band that migrated to the same location 
as the v-Src-SH3 binding 62 kDa protein (Fig. 3). 
In order to examine the possibility that the tyrosine phos-
phorylated protein is a 62 kDa protein other than the 
GAPA62, an effort was made to solubilize the 62 kDa protein 
from the RI pellet. As shown in Fig. 4, a 30 s sonication of 
the RI pellet prepared from V4 cells released a 62 kDa tyro-
sine phosphorylated protein, which retained the capacity to 
bind the GST-v-Src-SH3 and was immunoreactive with anti-
GAPA62 (Fig. 4). Fyn-SH3 did not associate with GAPA62 
but bound a 68 kDa protein that cross-reacted with anti-
GAPA62, and is likely to be Sam68. 
To determine whether the solubilized phosphorylated 62 
kDa protein is also the v-Src-SH3 binding protein, tyrosine-
phosphorylated proteins were immunoprecipitated from soni-
cated RI fraction of V4 cells with aPY. Following separation 
on SDS-polyacrylamide gel and blotting the recovered pro-
teins were analyzed by blot overlay with either GST-v-Src-
SH3 or GST-Fyn-SH3. The phosphorylated 62 kDa protein 
Fig. 4. Solubilization of RI proteins by sonication. RI pellet of V4 
cells was resuspended in Ca2+/Mg2+-free PBS and then sonicated 
for 30 s. Following centrifugation the supernatant was subjected to 
SDS-PAGE and the solubilized proteins were assayed by immuno-
blotting with either anti-GAPA62 or aPY, as well as by blot over-
lay with GST-v-Src-SH3 or GST-Fyn-SH3 followed by incubation 
with RaGST. Immunoreactive bands were visualized by ECL. 
Fig. 5. Precipitation of GAPA62 from solubilized RI pellet. The 
GAPA62 from RI fraction of V4 cells was solubilized by sonication 
and immunoprecipitated with agarose-linked aPY. The precipitated 
proteins were eluted with 2XSDS sample buffer and electrophoreti-
cally separated on SDS gels. The proteins were immunoblotted with 
either anti-GAPA62 or aPY. Other blots were assayed by blot over-
lay with GST-v-Src-SH3 or GST-Fyn-SH3 followed by incubation 
with RaGST. Control immunoprecipitations consisted of agarose 
beads carrying aPY that were similarly treated with 2XSDS sample 
buffer. IP, immunoprecipitates; C, controls. 
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has the capacity to associate with the v-Src-SH3 but not with 
the Fyn-SH3 (Fig. 5). Finally, the immunoprecipitate was 
immunoblotted with anti-GAPA62, revealing that the precipi-
tated protein is indeed the GAPA62 (Fig. 5). This experiment 
took advantage of the protein being tyrosine-phosphorylated 
and therefore was conducted using V4 cells that express the 
highest tyrosine phosphorylation state (cf. Fig. 2). In other 
experiments, conducted on NIH 3T3 cells, GST-v-Src-SH3 
immobilized on GSH-agarose was used to affinity-precipitate 
v-Src-SH3 binding proteins solubilized from the RI fraction 
by sonication. The recovered proteins were electrophoretically 
separated and immunoblotted with anti-GAPA62 antibody. 
Only one protein, a 62 kDa band, appeared to be immuno-
reactive (data not shown). These results strongly suggest that 
the 62 kDa protein is GAPA62. 
4. Discussion 
In order to study SH3-mediated interaction of Src, the SH3 
domain of v-Src was expressed in bacteria as a fusion with 
GST and used to probe SH3-binding proteins. The v-Src-SH3 
was found to associate with several blotted protein bands, but 
mainly with a 62-64 kDa doublet. Determination of phospho-
tyrosines revealed that the 62 kDa protein was tyrosine phos-
phorylated. The ability of the 62 kDa protein to associate 
with an SH3 domain and its phosphorylation on tyrosine 
residue(s) were similar to another protein, Sam68, raising 
the possibility that the p62 is the Sam68 homolog GAPA62. 
Indeed, the v-Src-SH3-binding 62 kDa protein co-migrated on 
SDS gels with GAPA62, and immunoprecipitation with ocPY 
antibodies followed by immunoblotting with anti-GAPA62 or 
blot overlay with v-Src-SH3, identified the tyrosine phos-
phorylated 62 kDa band as GAPA62 and the v-Src-SH3 bind-
ing protein. Our results are in apparent contrast to other 
studies that failed to identify GAPA62 as a major SH3-bind-
ing protein [29-31]. Those studies were carried out on a solu-
ble fraction of cells lysed with RIPA buffer, and binding of 
GAPA62 to SH3 was tested with GST-Fyn-SH3. Three fac-
tors may have prevented the detection of GAPA62 in those 
studies. First, as we show here, the GAPA62 does not asso-
ciate with the Fyn-SH3 and therefore the Fyn-SH3 cannot be 
used as a probe for detection of GAPA62 or for its precip-
itation. Second, proteins recovered after affinity-purification 
with immobilized SH3 were subjected to immunoblotting 
with aPY [30]. It is illustrated here that the RIPA-soluble 
form of GAPA62 is not tyrosine-phosphorylated. Last, in 
non-transformed cells GAPA62 is localized to RIPA-soluble 
and RIPA-insoluble fractions. However, in transformed cells 
exhibiting high level of basal tyrosine phosphorylation, 
GAPA62 is restricted to the RIPA-insoluble fraction, explain-
ing why it was not detected in RIPA-soluble fraction of Src-
overexpressor NIH 3T3 cells. Thus, it may be assumed that 
non-transformed cells exhibited the basal pattern in which 
GAPA62 is located in both RIPA-soluble and RIPA-insoluble 
fractions. The RIPA-insoluble GAPA62 form is tyrosine-
phosphorylated and it is the main form detected in trans-
formed cells. It should be noted, however, that both phos-
phorylated and non-phosphorylated forms bind v-Src-SH3. 
The significance of identifying GAPA62 as the major target 
for the v-Src-SH3 lies in its unique features. The GAPA62 
contains five putative SH3-binding sites, a K homology 
(KH)-like domain and high tyrosine content in its C-terminal 
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portion [32,33]. GAPA62 was previously shown to interact 
with poly(U) RNA and with total cell mRNA [32,34]. It 
was also demonstrated to interact with various SH2- and 
SH3-containing proteins such as Ras-GAP, Grb2, the p85 
regulatory subunit of the PI 3-kinase, PLCyl and Src 
[33,35-39]. Tyrosine phosphorylation of GAPA62, possibly 
by Src, has a dual effect. It increases GAPA62 association 
with SH2-containing proteins [36] and decreases its interaction 
with RNA [31,34]. The dissociation of GAPA62 from mRNA 
may enable a rapid, stimulus-dependent and Src-mediated 
modulation of mRNA transcription and/or translation [40-
42]. On the other hand, tyrosine-phosphorylated GAPA62 
may have a modulatory effect on various components of sig-
nal transduction pathways with which it interacts. Further-
more, association of GAPA62 with two or more proteins 
may bring them into close proximity, turning GAPA62 into 
an adaptor protein such as Grb2 or She [9,43,44]. Thus, 
GAPA62 may represent a new family of adaptor proteins 
that associate with various proteins as well as mRNA and 
DNA, whose ligand-binding properties and the nature of its 
current substrate are modulated by tyrosine phosphorylation. 
The present study suggests an additional role for tyrosine 
phosphorylation of GAPA62 in controlling its subcellular lo-
calization. The RI fraction is a nuclear-enriched fraction as 
was detected by the exclusive presence of the Al nuclear pro-
tein [45] in RI fraction of NIH 3T3 cells (data not shown). 
Therefore, it may be speculated that the target of phosphoryl-
ated GAPA62 depends on the type of tyrosine phosphoryla-
tion. While phosphorylation of certain tyrosine residues en-
hances the interaction with cytosolic or cytoskeletal proteins, 
phosphorylation of another subset of tyrosines promotes in-
teractions with nuclear proteins. Moreover, the possible re-
cruitment of all the GAPA62 into the nucleus of the trans-
formed V4 cells (evinced by its exclusive localization in the RI 
fraction; Fig. 3) implies a role for GAPA62 in cell transfor-
mation by the middle T antigen and supposedly other onco-
genes as well. 
The results presented here suggest a new pathway by which 
a signal may be transmitted downstream of Src, by phospho-
rylation of GAPA62 and modulation of its interactions with 
other proteins and mRNA/DNA. Therefore, GAPA62 may be 
a mediator of the effects of Src on various intracellular events. 
Further study is required in order to elucidate mechanism(s) 
regulating Src-GAPA62 interactions and to characterize the 
exact role(s) of GAPA62 in mediating the physiological and 
pathophysiological effects of Src. 
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